Variant report
Variant | nsv519804 |
---|---|
Chromosome Location | chr2:213563072-213570265 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7575556 | chr2:213563072-213563073 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs116720219 | chr2:213563154-213563155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577447179 | chr2:213563157-213563158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544878410 | chr2:213563161-213563162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146854778 | chr2:213563202-213563203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527592800 | chr2:213563207-213563208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148969390 | chr2:213563220-213563221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552237304 | chr2:213563262-213563263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189194579 | chr2:213563300-213563301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72935007 | chr2:213563311-213563312 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs376039059 | chr2:213563317-213563318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11678941 | chr2:213563338-213563339 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs548100969 | chr2:213563377-213563378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12479051 | chr2:213563406-213563407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536954219 | chr2:213563431-213563432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555032904 | chr2:213563464-213563465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567268085 | chr2:213563466-213563467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554906655 | chr2:213563467-213563468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12479054 | chr2:213563482-213563483 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs577408867 | chr2:213563495-213563496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185393861 | chr2:213563520-213563521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553556310 | chr2:213563522-213563523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534229704 | chr2:213563549-213563550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552979112 | chr2:213563588-213563589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544097924 | chr2:213569604-213569605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373909848 | chr2:213569622-213569623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182248232 | chr2:213569639-213569640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187132467 | chr2:213569667-213569668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375805028 | chr2:213569691-213569692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370136569 | chr2:213569710-213569711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146382811 | chr2:213569713-213569714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191149321 | chr2:213569720-213569721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527770465 | chr2:213569741-213569742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556418482 | chr2:213569806-213569807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182288044 | chr2:213569814-213569815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549486817 | chr2:213569821-213569822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567759043 | chr2:213569859-213569860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs367915570 | chr2:213569870-213569871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111268570 | chr2:213569876-213569877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370895514 | chr2:213569914-213569915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139406973 | chr2:213569936-213569937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs16849100 | chr2:213569983-213569984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs539363193 | chr2:213569996-213569997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:213558000-213563200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr2:213563200-213563600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr2:213569600-213570000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |